Introduction
Echocardiography is an important imaging technique providing real-time imaging that can be performed at the bedside and easily repeated as needed (Table 1). Before the era of highly active anti-retroviral therapy
(HAART), cardiac complications in HIV included pericardial effusion, dilated cardiomyopathy, myocarditis, endocarditis, pulmonary hypertension, cardiac neoplasm, coronary artery disease and drug-related cardiotoxicity [1, 2].
Cardiac abnormalities, although usually clinically silent, can be detected in necropsy series in the majority of infected HIV patients (40-60%) [3].Due to a better prophylaxis against opportunistic infections and as a result of longer survival due to the introduction of HAART therapy, non-infectious cardiovascular manifestations are more commonly detected [4]. Echocardiography can determine left ventricular (LV), right ventricular (RV) systolic and diastolic functions, as well as the presence and severity of valvular heart disease (both stenosis and regurgitation), and pericardial disease. Doppler echocardiography can provide an accurate assessment of cardiac output, pulmonary artery pressures, resistance and filling pressures (Table 2). Echocardiography provides independent prognostic information on patients’ morbidity and survival. Echocardiography is useful to detect cardiac abnormalities both in symptomatic and asymptomatic patients. The recent introduction of new technologies such as Doppler myocardial imaging, strain and strain-rate and three-dimensional echocardiography could help in identifying subtle cardiac abnormalities at an asymptomatic stage.
Table 2 Main parameters derived from transthoracic echocardiography
Left ventricular dimensions and function
Left ventricular diameters and volumes (systole and diastole), wall thickness (diastole)
Left ventricular mass (indexed to BSA, height...)
Shortening fraction (N>30%) and left ventricular ejection fraction (N>60%)
Aortic output, Qs (N 5 at 6 l/min)
Transmitral flow
Left ventricular filling pressures (Ea and E/Ea; Vp and E/Vp; Ap-Am)
Valves
Thickness, leaflet mobility, calcifications, mass or vegetation (size, mobility)
If valvular stenosis: valvular area, maximal and mean gradient
If valvular regurgitation: mechanism, regurgitant orifice area, volume and fraction
Atria (left and right)
Size (diameters, area, volume); atrial mass or thrombus
Right ventricular dimensions and function
Right atrium and ventricle (diameter, area, volumes)
Right ventricular systolic function (fractional area, systolic velocity at tricuspid annulus)
Vena cava and hepatic veins (size, influence of respiration)
Right atrial pressure
Pulmonary pressures (systolic, diastolic, mean) and resistances
Pulmonary output, Qp (N 5 a 6 l/min)
Qp/Qs
Pericardium
Thickness, effusion, tolerance, hemodynamic consequences
More on the topic Introduction:
- Introduction
- Introduction
- Introduction
- Introduction
- INTRODUCTION
- Introduction
- Contents
- Contents
- AVIAN CHOLERA
- Hare C., Neo D. (eds.). Trade Finance: Technology, Innovation and Documentary Credit. Oxford University Press,2021. — 417 p., 2021